News
Down 17.6% in 4 Weeks, Here's Why You Should You Buy the Dip in CF (CF)
A downtrend has been apparent in CF Industries (CF) lately with too much selling pressure. The stock has declined 17.6% over the past four weeks. However, given the fact that it is now in oversold
Down 22.3% in 4 Weeks, Here's Why Rapid7 (RPD) Looks Ripe for a Turnaround
Rapid7 (RPD) has been beaten down lately with too much selling pressure. While the stock has lost 22.3% over the past four weeks, there is light at the end of the tunnel as it is now in oversold
How Much Upside is Left in Crexendo (CXDO)? Wall Street Analysts Think 41.43%
Crexendo (CXDO) closed the last trading session at $6.01, gaining 4.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts See a 26.6% Upside in Hippo Holdings (HIPO): Can the Stock Really Move This High?
Shares of Hippo Holdings Inc. (HIPO) have gained 11% over the past four weeks to close the last trading session at $28.83, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Believe Integral Ad Science (IAS) Could Rally 48.33%: Here's is How to Trade
Integral Ad Science (IAS) closed the last trading session at $8.98, gaining 14.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Bears are Losing Control Over Yara International ASA (YARIY), Here's Why It's a 'Buy' Now
A downtrend has been apparent in Yara International ASA (YARIY) lately. While the stock has lost 5.4% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed
How Much Upside is Left in Soleno Therapeutics (SLNO)? Wall Street Analysts Think 43.15%
Shares of Soleno Therapeutics, Inc. (SLNO) have gained 1% over the past four weeks to close the last trading session at $82.35, but there could still be a solid upside left in the stock if
Bears are Losing Control Over First Financial (FFIN), Here's Why It's a 'Buy' Now
A downtrend has been apparent in First Financial Bankshares (FFIN) lately. While the stock has lost 6.6% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was
Blue Foundry Bancorp (BLFY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
A downtrend has been apparent in Blue Foundry Bancorp (BLFY) lately. While the stock has lost 8.3% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in
Orrstown (ORRF) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
A downtrend has been apparent in Orrstown Financial Services (ORRF) lately. While the stock has lost 7.4% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was
Here's Why Interactive Brokers Group, Inc. (IBKR) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Halozyme Therapeutics (HALO) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Nvidia (NVDA) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Why CBOE Global (CBOE) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Here's Why Assurant (AIZ) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Advanced Energy Industries (AEIS) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Why Trade Desk Crashed 40% Despite a Q2 Sales Beat
True to form, advertising technology stock The Trade Desk (NASDAQ: TTD) saw huge volatility after its latest earnings release. This time, it wasn’t for the better. Early morning trading on Aug
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Here's Why Steris (STE) is a Strong Growth Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates